blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1507775

EP1507775 - HETEROCYCLIC COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY ALPHA4 INTEGRINS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.11.2009
Database last updated on 24.08.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
ELAN PHARMACEUTICALS, INC.
800 Gateway Boulevard
South San Francisco, CA 94080 / US
[2009/01]
Former [2005/08]For all designated states
Elan Pharmaceuticals, Inc.
800 Gateway Boulevard
South San Francisco, CA 94080 / US
Inventor(s)01 / KONRADI, Andrei, W.
30 Victoria Road
Burlingame, CA 94010 / US
02 / SEMKO, Christopher, M.
4993 Norris Road
Fremont, CA 94536 / US
03 / XU, Ying-zi
793 Cereza Drive
Palo Alto, CA 94306 / US
04 / STAPPENBECK, Frank
1411 6th Avenue West
Seattle, WA 98119 / US
05 / STUPI, Brian, P.
421 Terrace Avenue, P.O. Box 239
Moss Beach, CA 94038 / US
06 / SMITH, Jenifer
331 Philip Drive, Apt. 103
Daily City, CA 94015 / US
07 / THORSETT, Eugene, D.
326 Purissima Street
Half Moon Bay, CA 94019 / US
08 / PLEISS, Michael, A.
848 Stelle Court
Sunnyvale, CA 94087 / US
 [2005/08]
Representative(s)Sexton, Jane Helen
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2005/08]Sexton, Jane Helen
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Application number, filing date03731419.227.05.2003
[2005/08]
WO2003US16804
Priority number, dateUS20020383020P24.05.2002         Original published format: US 383020 P
[2005/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03099809
Date:04.12.2003
Language:EN
[2003/49]
Type: A1 Application with search report 
No.:EP1507775
Date:23.02.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 04.12.2003 takes the place of the publication of the European patent application.
[2005/08]
Type: B1 Patent specification 
No.:EP1507775
Date:31.12.2008
Language:EN
[2009/01]
Search report(s)International search report - published on:US04.12.2003
(Supplementary) European search report - dispatched on:EP06.04.2006
ClassificationIPC:C07D401/10, A61P19/02, A61P29/00, A61K31/505, C07D239/69
[2006/21]
CPC:
C07D401/12 (EP,KR,US); A61P1/04 (EP); A61P11/06 (EP);
A61P19/02 (EP); A61P25/00 (EP); A61P25/28 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P35/04 (EP);
A61P37/06 (EP); A61P43/00 (EP); A61P9/10 (EP);
C07D239/50 (EP,US); C07D403/12 (EP,US) (-)
Former IPC [2005/08]C07D401/10, A61P19/02, A61P29/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/08]
Extension statesAL21.02.2005
LT21.02.2005
LV21.02.2005
MK21.02.2005
TitleGerman:HETEROCYCLISCHE VERBINDUNGEN, DIE DIE DURCH ALPHA4-INTEGRINE VERMITTELTE LEUKOZYTENADHÄSION INHIBIEREN[2005/08]
English:HETEROCYCLIC COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY ALPHA4 INTEGRINS[2005/08]
French:COMPOSES HETEROCYCLIQUES INHIBITEURS DE L'ADHESION LEUCOCYTAIRE PROVOQUEE PAR DES INTEGRINES ALPHA4[2005/08]
Entry into regional phase20.09.2004National basic fee paid 
20.09.2004Search fee paid 
20.09.2004Designation fee(s) paid 
20.09.2004Examination fee paid 
Examination procedure23.12.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
20.09.2004Amendment by applicant (claims and/or description)
20.09.2004Examination requested  [2005/08]
21.12.2007Despatch of a communication from the examining division (Time limit: M04)
10.04.2008Reply to a communication from the examining division
19.06.2008Communication of intention to grant the patent
17.10.2008Fee for grant paid
17.10.2008Fee for publishing/printing paid
Opposition(s)01.10.2009No opposition filed within time limit [2009/50]
Fees paidRenewal fee
13.05.2005Renewal fee patent year 03
27.03.2006Renewal fee patent year 04
14.05.2007Renewal fee patent year 05
25.03.2008Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT31.12.2008
BE31.12.2008
CY31.12.2008
CZ31.12.2008
EE31.12.2008
FI31.12.2008
RO31.12.2008
SI31.12.2008
SK31.12.2008
TR31.12.2008
BG31.03.2009
SE31.03.2009
GR01.04.2009
MC31.05.2009
PT01.06.2009
HU01.07.2009
[2011/43]
Former [2011/31]AT31.12.2008
BE31.12.2008
CZ31.12.2008
EE31.12.2008
FI31.12.2008
RO31.12.2008
SI31.12.2008
SK31.12.2008
BG31.03.2009
SE31.03.2009
GR01.04.2009
MC31.05.2009
PT01.06.2009
HU01.07.2009
Former [2010/48]AT31.12.2008
BE31.12.2008
CZ31.12.2008
EE31.12.2008
FI31.12.2008
RO31.12.2008
SI31.12.2008
SK31.12.2008
BG31.03.2009
SE31.03.2009
GR01.04.2009
MC31.05.2009
PT01.06.2009
Former [2010/08]AT31.12.2008
BE31.12.2008
CZ31.12.2008
EE31.12.2008
FI31.12.2008
RO31.12.2008
SI31.12.2008
SK31.12.2008
BG31.03.2009
SE31.03.2009
MC31.05.2009
PT01.06.2009
Former [2010/04]AT31.12.2008
BE31.12.2008
CZ31.12.2008
EE31.12.2008
FI31.12.2008
RO31.12.2008
SI31.12.2008
SK31.12.2008
SE31.03.2009
MC31.05.2009
PT01.06.2009
Former [2009/43]AT31.12.2008
BE31.12.2008
CZ31.12.2008
EE31.12.2008
FI31.12.2008
RO31.12.2008
SI31.12.2008
SK31.12.2008
SE31.03.2009
PT01.06.2009
Former [2009/39]AT31.12.2008
BE31.12.2008
CZ31.12.2008
EE31.12.2008
FI31.12.2008
RO31.12.2008
SI31.12.2008
SE31.03.2009
PT01.06.2009
Former [2009/36]BE31.12.2008
EE31.12.2008
FI31.12.2008
RO31.12.2008
SI31.12.2008
Former [2009/32]BE31.12.2008
FI31.12.2008
SI31.12.2008
Former [2009/26]FI31.12.2008
SI31.12.2008
Documents cited:Search[A]WO0043369  (ELAN PHARM INC [US], et al) [A] 1,8-11,19-23 * claim -; table 1 *;
 [A]WO0208201  (ELAN PHARM INC [US], et al) [A] 1,8-11,23-29* claims 1,10,23-26 *
International search[AP]US6492372  (KONRADI ANDREI W [US], et al)
by applicant   - LI ET AL., ARTERIOSCLER. THROMB., (1993), vol. 13, page 197
    - SASSEVILLE ET AL., ANI. J. PATH., (1994), vol. 144, page 27
    - YANG ET AL., PROC. NAT. ACAD. SCIENCE, (1993), vol. 9Q, page 10494
    - BURKLY ET AL., DIABETES, (1994), vol. 43, page 529
    - BARON ET AL., J. CLIN. INVEST., (1994), vol. 93, page 1700
    - HAMANN ET AL., J. IMMUNOLOGY, (1994), vol. 152, page 3283
    - YEDNOCK ET AL., NATURE, (1992), vol. 356, page 63
    - BARON ET AL., J. EXP. MED., (1993), vol. 177, page 57
    - VAN DINTHER-JANSSEN ET AL., J. IMMUNOLOGY, (1991), vol. L41, page 4207
    - VAN DINTHER-JANSSEN ET AL., ANNALS. RHEUMATIC DIS., (1993), vol. 52, page 672
    - ELICES ET AL., J. CLIN. INVEST., (1994), vol. 93, page 405
    - POSTIGO ET AL., J: CLIN. INVEST., (1991), vol. 89, page 1445
    - PAUL ET AL., TRANSPL. PROCEED., (1993), vol. 25, page 813
    - OKARHARA ET AL., CAN. RES., (1994), vol. 54, page 3233
    - PAAVONEN ET AL., INT. J. CAN., (1994), vol. 58, page 298
    - SCHADENDORF ET AL., J. PATH., (1993), vol. 170, page 429
    - BAO ET AL., DIFF., (1993), vol. 52, page 239
    - LAURI ET AL., J. CANCER, (1993), vol. 68, page 862
    - KAWAGUCHI ET AL., JAPANESE J. CANCER RES., (1992), vol. 83, page 1304
    - ABRAHAM ET AL., J.CLIN, INVEST, (1994), vol. 93, pages 776 - 787
    - ABRAHAM ET AL., AM J. RESPIR CRIT CARE MED, (1997), vol. 156, pages 696 - 703
 WO2000US01686
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.